ATE234088T1 - Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol - Google Patents

Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol

Info

Publication number
ATE234088T1
ATE234088T1 AT93922310T AT93922310T ATE234088T1 AT E234088 T1 ATE234088 T1 AT E234088T1 AT 93922310 T AT93922310 T AT 93922310T AT 93922310 T AT93922310 T AT 93922310T AT E234088 T1 ATE234088 T1 AT E234088T1
Authority
AT
Austria
Prior art keywords
taxol
treatment
lymphomas
breast cancer
drug resistance
Prior art date
Application number
AT93922310T
Other languages
English (en)
Inventor
Wyndham H Wilson
Robert Wittes
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE234088T1 publication Critical patent/ATE234088T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AT93922310T 1992-09-22 1993-09-22 Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol ATE234088T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95038092A 1992-09-22 1992-09-22
PCT/US1993/008983 WO1994006422A1 (en) 1992-09-22 1993-09-22 Use of taxol for treating lymphomas and breast cancer

Publications (1)

Publication Number Publication Date
ATE234088T1 true ATE234088T1 (de) 2003-03-15

Family

ID=25490363

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93922310T ATE234088T1 (de) 1992-09-22 1993-09-22 Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol

Country Status (8)

Country Link
US (2) US5496846A (de)
EP (1) EP0661969B1 (de)
JP (1) JP3020277B2 (de)
AT (1) ATE234088T1 (de)
AU (1) AU680441B2 (de)
CA (1) CA2145190A1 (de)
DE (1) DE69332758D1 (de)
WO (1) WO1994006422A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994341A (en) * 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
GB2340493B (en) * 1995-08-31 2000-06-21 Roslin Inst Unactivated oocytes as cytoplast recipients for nuclear transfer
US7332648B2 (en) 1995-08-31 2008-02-19 Roslin Institute Unactivated oocytes in nuclear transfer to produce cultured inner cell mass cells and ungulates
GB9517780D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
ATE302599T1 (de) 1996-05-24 2005-09-15 Angiotech Pharm Inc Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
AU3740997A (en) * 1996-08-26 1998-03-19 Bristol-Myers Squibb Company Sulfenamide taxane derivatives
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US7361804B1 (en) 1997-02-19 2008-04-22 Roslin Institute (Edinburgh) Unactivated oocytes in nuclear transfer to produce ungulates
JP3896435B2 (ja) * 1997-12-17 2007-03-22 アークレイ株式会社 センサおよびセンサ集合体
WO1999049848A1 (en) * 1998-04-01 1999-10-07 Rtp Pharma Inc. Anticancer compositions
EP1171117A4 (de) * 1999-04-22 2002-08-07 American Bioscience Inc Langzeitverabreichung von pharmakologisch aktiven mitteln
EP1685835A3 (de) * 1999-04-22 2006-08-09 American Bioscience, Inc. Langzeitapplikation subtherapeutischer Mengen pharmakologischer Wirkstoffe
US6294546B1 (en) * 1999-08-30 2001-09-25 The Broad Of Trustees Of The Leland Stanford Junior University Uses of diterpenoid triepoxides as an anti-proliferative agent
AU2001253336A1 (en) 2000-04-10 2001-10-23 Teva Pharmaceutical Industries Ltd. Method 0f administration of paclitaxel-plasma protein formulation
US6410059B1 (en) * 2000-10-20 2002-06-25 Council Of Scientific And Industrial Research Pharmaceutical composition containing cow urine distillate and an antibiotic
CZ294371B6 (cs) * 2002-06-10 2004-12-15 Pliva - Lachema, A. S. Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
CN1921891B (zh) 2004-01-27 2010-11-10 南佛罗里达大学 连接到杯芳烃上的生长因子结合化合物
CN1980929A (zh) * 2004-02-24 2007-06-13 比奥阿克松医疗技术股份有限公司 4－取代哌啶衍生物
US7989490B2 (en) * 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US7459562B2 (en) * 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
US20060252823A1 (en) * 2005-05-04 2006-11-09 Deck Lorraine M Isocoumarin-based inhibitors of urokinase-type plasminogen activator
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
WO2008039482A2 (en) * 2006-09-26 2008-04-03 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US20080227853A1 (en) * 2007-03-13 2008-09-18 Bionature E. A. Limited Androgene membrane receptor agonist
US8403291B2 (en) * 2007-06-21 2013-03-26 Michael Wallace Howlett Tube slide clamp with extending finger grips
FR2933405B1 (fr) * 2008-07-03 2010-08-13 Centre Nat Rech Scient Derives ferroceniques a activite anticancereuse
US10149856B2 (en) 2015-01-26 2018-12-11 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10857157B2 (en) 2015-01-26 2020-12-08 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10106525B2 (en) 2015-01-26 2018-10-23 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US11198680B2 (en) 2016-12-21 2021-12-14 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
WO2019014322A1 (en) 2017-07-11 2019-01-17 BioAxone BioSciences, Inc. KINASE INHIBITORS FOR THE TREATMENT OF DISEASES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630454B2 (en) * 2001-09-10 2003-10-07 Ramot At Tel-Aviv University Ltd. Method and pharmaceutical composition for the treatment of cancer

Also Published As

Publication number Publication date
JPH08501560A (ja) 1996-02-20
DE69332758D1 (de) 2003-04-17
USRE40839E1 (en) 2009-07-07
JP3020277B2 (ja) 2000-03-15
EP0661969A1 (de) 1995-07-12
WO1994006422A1 (en) 1994-03-31
AU680441B2 (en) 1997-07-31
US5496846A (en) 1996-03-05
AU5135793A (en) 1994-04-12
CA2145190A1 (en) 1994-03-31
EP0661969B1 (de) 2003-03-12

Similar Documents

Publication Publication Date Title
ATE234088T1 (de) Taxol zur behandlung von lymphomen und brustkrebs und zur verminderung der multi-drug resistenz gegen taxol
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69213814T2 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
DE69202441T2 (de) Melatoninderivate und Kombinationen mit Antiestrogenen zur Behandlung von Brustkarzinoma.
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
DE59605959D1 (de) Verwendung von Immunglobulin-Präparationen zur Herstellung eines Medikaments zur oralen Verabreichung zur Behandlung und Prophylaxe chronischer Schmerzzustände
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
KR890000108A (ko) 종양 치료용 약제학적 조성물
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
ATE195876T1 (de) Reinigung einer den müller-mischtumor inhibierenden substanz und behandlung von einigen tumoren
DE68909750T2 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
KR890001555A (ko) 요산 배설용 조성물
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
DE69528068T2 (de) Conagenine zur prävention und behandlung von diarrhöe
KR930702016A (ko) 골다공증 치료제

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties